Erratum: CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models
Erratum to: Transl Cancer Res 2020;9:1903-13.
In the article titled “CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models”, published in Translational Cancer Research (1), an error was identified in Figure 1A.
The image labeled as “Normal” in Figure 1A was incorrect due to an error made during image assembly. The corrected immunohistochemical staining image of normal colonic mucosa is provided below. This correction does not affect the results, discussion, or conclusions of the article.
The authors sincerely apologize for this oversight.
Corrected Figure 1A (normal colonic tissue):
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Ren F, Zhu J, Li K, et al. CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models. Transl Cancer Res 2020;9:1903-13. [Crossref]
